Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097981
Status:
COMPLETED
Last Update Posted:
2017-04-07
First Post:
2004-12-01
Brief Title:
A Study of Thalidomide Plus Dexamethasone Thal-Dex Versus DOXIL plusThalidomide Plus Dexamethasone DOXIL -Thal-Dex in Patients With Newly Diagnosed Multiple Myeloma
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Organization Data
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Class:
INDUSTRY
Study ID:
CR004579
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Tibotec Therapeutics a Division of Ortho Biotech Products LP USA | INDUSTRY |